For the Inventor, By the Inventor

Enter assignee name

Hong Kong, China

Hepagene Therapeutics (Hk) Limited

USPTO Granted Patents = 4

Forward Citations = 0

Loading Chart...

Loading Chart...

3 inventors (with patents filed for the assignee):

Xiaodong Xu (3 out of 18 patents)

Ben Li (1 out of 3 patents)

Shanghai Yu (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12378268 - Heterocyclic THR-β receptor agonist compound and preparation method and use therefor (2025-08-05),

2. 11427556 - Urea derivatives as inhibitors of ASK1 (2022-08-30),

3. 10919903 - Nitrogen-containing heterocyclic compounds as FXR modulators (2021-02-16),

4. 10899723 - Heterocyclic containing cyclopropyl FXR modulators (2021-01-26),

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

4 Patents

#715 in Hong Kong

#5,610 in China

Hong Kong, China

Hepagene Therapeutics (Hk) Limited

Forward Citations = 0

3 inventors:

Xiaodong Xu (3 out of 18 patents)

Ben Li (1 out of 3 patents)

Shanghai Yu (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

Loading…